IPO Details
RHP/DRHPIssue Date
27 May - 29 May'25
Investment/lot
₹ 135000
Price Range
128 - 135
Lot Size
1000
IPO Size
₹ 37.66 Cr
IPO Listing Details
Listing On
3 Jun'25
Issue Price
135
Listed Price
₹ 137.45
Retail Gain/Listing Gain
▲1.81%
Schedule of Astonea Labs IPO
Start date
27/05/2025
End date
29/05/2025
Allotment of bids
30/05/2025
Refund Initiation
02/06/2025
Listing on exchange
03/06/2025
About Astonea Labs IPO
The IPO of Astonea Labs Ltd comprises a fresh issue of up to 27,90,000 equity shares of face value of ₹10 each. There’s no offer for sale in this 100% book-built issue. The price band of the IPO ranges between ₹128 and ₹135. The lot size is 1000 shares.
The credit of shares to the demat account will take place on June 2, 2025. The listing of shares on the stock exchanges will take place on June 3, 2025. The initiation of refunds will take place on June 2, 2025. The tentative allotment date is May 30, 2025.
Objectives of Astonea Labs IPO
- Funding of expenses proposed to be incurred towards product registration in Bolivia
- Purchase and installation of plant and machineries for ointment production for the purpose of export in accordance with the international standards and protocols at Haripur, Haryana
- Advertising, marketing and brand building
- Investment in procuring hardware and software
- Funding of working capital requirements
- General corporate purposes
Astonea Labs IPO Valuation
| Detail | Information |
|---|---|
Upper Price Band | ₹135 |
Fresh Issue | Fresh issue of up to 27,90,000 equity shares |
Offer for Sale | NA |
EPS in ₹ for FY 24 | 5.01 |
Astonea Labs IPO Share Offer and Subscription Details
| Investor Category | Shares Offered |
|---|---|
QIBs | Not more than 50% of the issue size |
Non-institutional Bidders | Not less than 15% of the issue size |
Retail Individual Bidders | Not less than 35% of the issue size |
Industry Outlook
India’s domestic pharmaceutical market stood at US$ 42 billion in 2021 and is likely to expand to reach US$ 120-130 billion by 2030. Also, the cosmetic industry in India has emerged as a luminous gem in the country's economic landscape.
On the other hand, the Indian cosmetics sector is currently going through a phase of tremendous expansion. The market for cosmetics in India was estimated to be worth US$ 11.6 billion in 2017 and is projected to expand at a CAGR of 15-20% from 2017 to 2025.
Company Information
Astonea Labs Ltd specialises in the manufacturing and marketing of a wide range of pharmaceutical and cosmetic products. These include antibiotic drugs, anti-cold medications, antihistamines, and drugs for diabetes, cardiovascular diseases, gynaecological concerns, analgesics, fungal infections, and multivitamins. It also offers products for skin, tooth, and hair care, available in various forms such as gels, ointments, creams, lotions, oils, and serums.
Astonea Labs Strengths
Scalable Business Model
Astonea Labs Ltd believes that it has a scalable business model as its business model is customer-centric and order-driven, and requires optimum utilisation of its existing resources, assuring quality supply and achieving consequent economies of scale. The business scale generation is basically due to the development of new markets and products in both domestic and international markets by exploring customer needs, marketing expertise, and consistent product quality.
Wide and Diverse Range of Product Offerings
The company has a wide product portfolio comprising pharmaceutical and cosmetic products such as antibiotics drugs, anti-cold drugs, antihistamine drugs, drugs for diseases like diabetes, cardiovascular diseases, gynaecological concerns, analgesics, fungal infections, and multivitamins, and products for skin and hair care in form of tablets, capsules, gels, creams, and lotions, oil, serum all of which adhere to the rigorous standards of the pharmaceutical and cosmetic industries.
Quality Service
The company believes in providing quality and timely service to its customers. It has set very high standards for itself when it comes to timeliness and quality of service it provides to its customers. The stringent systems ensure that all the products reach its customers on stipulated time and there are minimal errors to ensure reduced product rejection. It believes that its quality service has earned it goodwill from its customers, which has resulted in customer retention and order repetition.
Risks of Astonea Labs IPO
- Dependence on Third-party for Supply of Raw Materials
The company is dependent on third parties for the supply of raw materials and such third parties could fail in meeting their obligations, which may have a material adverse effect on its business, results of operations and financial condition.
- Reliance on Pharmaceutical Sales
The company’s business is significantly dependent on the revenue generated by manufacturing and selling the pharmaceuticals, which constitutes a substantial portion of its sales and such dependence exposes it to various risks that could materially affect its business operations, financial condition, and results of operations.
- Majority Revenue from Contract Manufacturing
Major revenue of the company is generated from contract manufacturing and any adverse factors affecting the outsourcing of manufacturing by their customers could have an adverse effect on its business, results of operations and financial condition.
All Financial Information about Astonea Labs
Particulars (in Rs. crores)
Particulars (in Rs. crores)
Comparison with peers
| Company Name | Total Income (in ₹ crores) | EPS in ₹ | Return on Net Worth (in %) | NAV per Share (in ₹) |
|---|---|---|---|---|
Astonea Labs Ltd | 80.2885 | 5.01 | 31.83 | 15.75 |
Beta Drugs Ltd | 297.0726 | 37.90 | 23.19 | 163.43 |
Anchor Investor Bidding Date TBA
IPO Registrar and Book Running Lead Manager
- IPO Registrar: KFin Technologies Ltd
- Book Running Lead Manager: Oneview Corporate Advisors Pvt Ltd
Business Model
Astonea Labs Ltd manufactures and markets its cosmetic skin and hair care products namely “Glow Up” which was launched in the year 2022. Additionally, it introduced its pharmaceutical product line, "Regero," in 2024. Its commitment with these brands is to provide high-quality, affordable products that cater to the diverse needs of its customers.
Company Growth Trajectory
The revenue from operations of Astonea Labs Ltd grew from ₹30.0569 crores in FY 22 to ₹80.1909 crores in FY 24. Its PAT margin increased from 0.83% in FY 22 to 4.75% in FY 24. Experienced management, dedicated employee base and a scalable business model have helped in the company’s growth.
Market Position
Astonea Labs Ltd is based in Haryana, India equipped with a state-of-the-art manufacturing facility having a core manufacturing area of 7,500 square meters, meticulously designed and operated in strict conformity with ISO standards.
The company also exports its products directly to countries such as Iraq and Yemen. To further advance its export business directly, it has recently undergone an audit by the USFDA for OTC products and has submitted the compliance report. The milestone of USFDA for OTC products is significant as it positions it to expand its presence in the United States market and several other countries.
Astonea Labs IPO Profit and Loss
| Parameter | FY 24 | FY 23 | FY 22 |
|---|---|---|---|
Total Income (in ₹ crores) | 80.2885 | 67.2586 | 30.1746 |
Profit / (Loss) Before Tax (in ₹ crores) | 5.1052 | 1.0812 | 0.5788 |
Profit After Tax (in ₹ crores) | 3.8098 | 0.6652 | 0.2488 |
EPS in ₹ | 5.01 | 0.88 | 0.33 |
Astonea Labs IPO Cash Flow Statement
| Parameter | FY 24 | FY 23 | FY 22 |
|---|---|---|---|
Total Income (in ₹ crores) | 80.2885 | 67.2586 | 30.1746 |
Profit / (Loss) Before Tax (in ₹ crores) | 5.1052 | 1.0812 | 0.5788 |
Profit After Tax (in ₹ crores) | 3.8098 | 0.6652 | 0.2488 |
EPS in ₹ | 5.01 | 0.88 | 0.33 |
How to Check Allotment Status of Astonea Labs IPO?
1. Visit the Registrar's Website
- Go to the official website of KFin Technologies Ltd
- Click on ‘IPO Allotment Status’ under ‘Investors’ under ‘Products’
- Click on the any one of the links
- Choose IPO Name, enter application number, Demat account number or PAN number
- Enter captcha and click on ‘Submit’
2. Check on Bombay Stock Exchange Website
The Bombay Stock Exchange (BSE) also has an IPO allotment status page. Go to www.bseindia.com and find the 'Investor Services' tab. Under 'Investors Services', click on 'Status of Issue Application'. This will take you to the IPO allotment status page. On the BSE IPO page, follow these steps:
- Choose the Issue Type
- Select the Issue Name from dropdown
- Put in either your application number or PAN number
- Check the box ‘I’m not a robot’
- Click on ‘Search’ to know allotment status
How to Apply for Astonea Labs IPO?
- Log in to your Kotak Securities Demat account - Log in to your Demat account to access IPO investments. Next, select the current IPO section.
- Specify IPO details - Enter the number of lots and the price you wish to apply for.
- Enter UPI ID - After entering your UPI ID, click submit. This will place your bid with the exchange.
- Mandate Notification - Your UPI app will receive a mandate notification to block funds.
- Approve Request - Your funds will be blocked once you approve the mandate request on your UPI.
This article is for informational purposes only and does not constitute financial advice. It is not produced by the desk of the Kotak Securities Research Team, nor is it a report published by the Kotak Securities Research Team. The information presented is compiled from several secondary sources available on the internet and may change over time. Investors should conduct their research and consult with financial professionals before making any investment decisions. Read the full disclaimer here.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing. Please read the SEBI-prescribed Combined Risk Disclosure Document before investing. Brokerage will not exceed SEBI’s prescribed limit.
Astonea Labs IPO FAQs
When is Astonea Labs IPO listing date?
Astonea Labs IPO will list on 2025-06-03.
What is the issue size of Astonea Labs IPO?
37.66 is the issue size of Astonea Labs IPO.
What is the minimum lot size required for Astonea Labs IPO?
The minimum lot size is 1000 shares and the investment required is ₹135000.
What is the price band of the Astonea Labs IPO?
The price band of Astonea Labs IPO is ₹128 to ₹135.
Where can I read more about Astonea Labs business?
You can read more about Astonea Labs and its IPO from the company’s red herring prospectus (RHP) here.
What is the Astonea Labs Ltd IPO?
The IPO of Astonea Labs Ltd comprises a fresh issue of up to 27,90,000 equity shares of face value of ₹ 10 each.
When will the IPO of Astonea Labs Ltd go live?
The IPO of Astonea Labs Ltd will go live on May 27, 2025.
From where can I read more about the IPO of Astonea Labs Ltd?
You can read more about the IPO of Astonea Labs Ltd from the company’s red herring prospectus here.
